{"id":"W1981574714","doi":"10.1007/s00415-011-6275-7","title":"Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS","year":2011,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Natalizumab; Expanded Disability Status Scale; Medicine; Multiple sclerosis; Placebo; Internal medicine; Neurology; Clinical endpoint; Clinical trial; Immunology; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001572573,0.0001435225,0.0009400719,0.000394213,0.00005108586,0.000008950966,0.0001722316,0.0001341313,0.01751981],"category_scores_gemma":[0.02629823,0.0001091761,0.0002886135,0.0001550849,0.0001541169,0.0001182111,0.0001019705,0.000959122,0.00004929312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004713303,"about_ca_system_score_gemma":0.0001514952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004560708,"about_ca_topic_score_gemma":0.00002624986,"domain_scores_codex":[0.9970173,0.0007707234,0.001212207,0.0002072114,0.0004739403,0.0003186668],"domain_scores_gemma":[0.993719,0.005031977,0.0007078756,0.000166669,0.0002074338,0.000167091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.0532751,0.005036773,0.1509982,0.0001219613,0.002155889,0.01535615,0.005944596,0.00003642434,0.07644314,0.0001452787,0.6088986,0.08158782],"study_design_scores_gemma":[0.007965571,0.00182723,0.9740935,0.0002186,0.00005656497,0.0009122577,0.00005241255,0.00007188357,0.0008800376,0.0003085528,0.01351615,0.00009722924],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945635,0.0002478373,0.00002367745,0.00157396,0.0005677344,0.0001982664,0.0004004069,0.00001255222,0.002412115],"genre_scores_gemma":[0.9960232,0.0002071643,0.00193328,0.0006787831,0.001022816,0.000007908047,0.00005804696,0.00002195795,0.00004687283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8230953,"threshold_uncertainty_score":0.9833783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1736209135993706,"score_gpt":0.3586830282784313,"score_spread":0.1850621146790607,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}